These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Endothelial insulin resistance protects the heart against prolonged ischemia-reperfusion injury but does not prevent insulin transport across the endothelium in a mouse Langendorff model. Sharma V; Kearney MT; Davidson SM; Yellon DM J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):586-91. PubMed ID: 24651518 [TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress. Virdis A; Colucci R; Fornai M; Blandizzi C; Duranti E; Pinto S; Bernardini N; Segnani C; Antonioli L; Taddei S; Salvetti A; Del Tacca M J Pharmacol Exp Ther; 2005 Mar; 312(3):945-53. PubMed ID: 15547110 [TBL] [Abstract][Full Text] [Related]
7. Selective Enhancement of Insulin Sensitivity in the Endothelium In Vivo Reveals a Novel Proatherosclerotic Signaling Loop. Viswambharan H; Yuldasheva NY; Sengupta A; Imrie H; Gage MC; Haywood N; Walker AM; Skromna A; Makova N; Galloway S; Shah P; Sukumar P; Porter KE; Grant PJ; Shah AM; Santos CX; Li J; Beech DJ; Wheatcroft SB; Cubbon RM; Kearney MT Circ Res; 2017 Mar; 120(5):784-798. PubMed ID: 27920123 [TBL] [Abstract][Full Text] [Related]
8. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. Vicent D; Ilany J; Kondo T; Naruse K; Fisher SJ; Kisanuki YY; Bursell S; Yanagisawa M; King GL; Kahn CR J Clin Invest; 2003 May; 111(9):1373-80. PubMed ID: 12727929 [TBL] [Abstract][Full Text] [Related]
9. Selective impairment of blood pressure reduction by endothelial nitric oxide synthase dimer destabilization in mice. Suvorava T; Pick S; Kojda G J Hypertens; 2017 Jan; 35(1):76-88. PubMed ID: 27861245 [TBL] [Abstract][Full Text] [Related]
10. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779 [TBL] [Abstract][Full Text] [Related]
11. Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation. Zhou MS; Schulman IH; Raij L J Hypertens; 2010 Mar; 28(3):527-35. PubMed ID: 19898250 [TBL] [Abstract][Full Text] [Related]
12. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Montagnani M; Ravichandran LV; Chen H; Esposito DL; Quon MJ Mol Endocrinol; 2002 Aug; 16(8):1931-42. PubMed ID: 12145346 [TBL] [Abstract][Full Text] [Related]
13. Vascular insulin-like growth factor-I resistance and diet-induced obesity. Imrie H; Abbas A; Viswambharan H; Rajwani A; Cubbon RM; Gage M; Kahn M; Ezzat VA; Duncan ER; Grant PJ; Ajjan R; Wheatcroft SB; Kearney MT Endocrinology; 2009 Oct; 150(10):4575-82. PubMed ID: 19608653 [TBL] [Abstract][Full Text] [Related]
14. Preserved glucoregulation but attenuation of the vascular actions of insulin in mice heterozygous for knockout of the insulin receptor. Wheatcroft SB; Shah AM; Li JM; Duncan E; Noronha BT; Crossey PA; Kearney MT Diabetes; 2004 Oct; 53(10):2645-52. PubMed ID: 15448096 [TBL] [Abstract][Full Text] [Related]
15. Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. Choi YJ; Yoon Y; Lee KY; Hien TT; Kang KW; Kim KC; Lee J; Lee MY; Lee SM; Kang DH; Lee BH FASEB J; 2014 Jul; 28(7):3197-204. PubMed ID: 24652948 [TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4. Liang CF; Liu JT; Wang Y; Xu A; Vanhoutte PM Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):777-84. PubMed ID: 23413427 [TBL] [Abstract][Full Text] [Related]
18. Pitavastatin restores vascular dysfunction in insulin-resistant state by inhibiting NAD(P)H oxidase activity and uncoupled endothelial nitric oxide synthase-dependent superoxide production. Shinozaki K; Nishio Y; Ayajiki K; Yoshida Y; Masada M; Kashiwagi A; Okamura T J Cardiovasc Pharmacol; 2007 Mar; 49(3):122-30. PubMed ID: 17414223 [TBL] [Abstract][Full Text] [Related]
19. Nur77 mitigates endothelial dysfunction through activation of both nitric oxide production and anti-oxidant pathways. Lu L; Jang S; Zhu J; Qin Q; Sun L; Sun J Redox Biol; 2024 Apr; 70():103056. PubMed ID: 38290383 [TBL] [Abstract][Full Text] [Related]